NVON.NEO NOVO NORDISK A/S CDR (CAD Hedged)

4.30 CAD
Close of Oct 30, 2026
3.65 6.25
Total assets
-
Expense ratio
-
Dividend yield
-
1-year return
-
Holdings
1
Since
-

Fund data as reported by the issuer, updated Oct 30, 2026. Total assets are in the fund's base currency.

What does NVON.NEO invest in?

The holdings of NOVO NORDISK A/S CDR (CAD Hedged) are not available yet.

NOVO NORDISK A/S CDR (CAD Hedged) performance

Sharpe ratio 0.00

Return figures of NOVO NORDISK A/S CDR (CAD Hedged) are not available yet.

NVON.NEO price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About NOVO NORDISK A/S CDR (CAD Hedged)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone repla…

Full fund profile